For example, single nucleotide polymorphisms (SNPs) in DRD1 and DRD2 are considered potential risk factors for ADHD [78], suggesting that the target of MPH is not only DAT; and more importantly, our results support an important role for DA receptors in MPH treatment. This evidence concerns the gene DRD1 and attention deficit-hyperactivity disorder.